Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings will go public soon. The estimated IPO date is May 1, 2026.

IPO Price Range

$16.00 - $18.00

Shares Offered

11,764,706

Deal Size

$200.00M

COAG Statistics

Total Valuation

COAG has a market cap or net worth of $666.53 million. The enterprise value is $482.26 million.

Market Cap	666.53M
Enterprise Value	482.26M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

COAG has 39.21 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	39.21M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	33.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-32.81%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$887,681
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-227,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.12M
Pretax Income	-64.14M
Net Income	-63.91M
EBITDA	-65.81M
EBIT	-66.11M
Earnings Per Share (EPS)	-$1.63

Full Income Statement

Balance Sheet

The company has $185.49 million in cash and $1.22 million in debt, giving a net cash position of $184.27 million or $4.70 per share.

Cash & Cash Equivalents	185.49M
Total Debt	1.22M
Net Cash	184.27M
Net Cash Per Share	$4.70
Equity (Book Value)	-176.64M
Book Value Per Share	-4.51
Working Capital	181.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.48 million and capital expenditures -$16,000, giving a free cash flow of -$61.49 million.

Operating Cash Flow	-61.48M
Capital Expenditures	-16,000
Depreciation & Amortization	304,000
Net Borrowing	-120,000
Free Cash Flow	-61.49M
FCF Per Share	-$1.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

COAG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.59%
FCF Yield	-9.23%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a